FDA.reportPublic FDA data

Application 078391

Type
ANDA
Sponsor
JUBILANT CADISTA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDECAPSULE;ORAL12.5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42291-315HydrochlorothiazideHydrochlorothiazideAvKARE, Inc.ANDACurrent
42291-315HydrochlorothiazideHydrochlorothiazideAvKAREANDACurrent
50090-3186HydrochlorothiazideHydrochlorothiazideA-S Medication SolutionsANDACurrent
50090-3186HydrochlorothiazideHydrochlorothiazideA-S Medication SolutionsANDACurrent
50436-6733HydrochlorothiazideHydrochlorothiazideUnit Dose ServicesANDACurrent
59746-382HydrochlorothiazideHydrochlorothiazideJUBILANT CADISTA PHARMACEUTICALS INC.ANDACurrent
59746-382HydrochlorothiazideHydrochlorothiazideJUBILANT CADISTA PHARMACEUTICALS INC.ANDACurrent
69375-001HydrochlorothiazideHydrochlorothiazideNationwide Pharmaceutical, LLCANDACurrent
69375-001HydrochlorothiazideHydrochlorothiazideNationwide Pharmaceutical, LLCANDACurrent
70518-0593HydrochlorothiazideHydrochlorothiazideREMEDYREPACK INC.ANDACurrent
70518-0593HydrochlorothiazideHydrochlorothiazideREMEDYREPACK INC.ANDACurrent
71610-139HydrochlorothiazideHydrochlorothiazideAphena Pharma Solutions - Tennessee, LLCANDACurrent